Honda's Hesitation on Canadian Battery Production
Honda expresses caution towards battery manufacturing in Canada, reflecting strategic considerations in the evolving automotive industry.
Topic
KeyInfo
A collection of 7573 issues
Honda Motors Hesitant on EV Production Amid Trump's Policy Uncertainty
Honda Motors cautious on electric vehicle production due to President-elect Trump's uncertain industrial policy. Explore more about the impact on EV market.
Investor Concerns Over China's Economy Amid Global Oil Surplus
Explore the impact of China's economic concerns on global markets amidst abundant crude supplies. Learn how these dynamics affect investors and industries.
Exxon Balances $400 Million Asset Sale Gains with Charges
ExxonMobil anticipates a $400 million gain from asset sales, matched by equivalent charges. Explore how this impacts their financial strategy.
Natural Gas Boosts Earnings Amid Declining Chemical Margins
Natural gas prices increased earnings by $200 million, offsetting declines in chemical margins. Explore the impact on the industry and future prospects.
Exxon Mobil Faces $1.2 Billion Earnings Hit in Q4 2024
Exxon Mobil Corp. anticipates a $1.2 billion earnings reduction in Q4 2024 due to decreased crude prices and refining margins, impacting financial performance.
Sanofi Ends Maze Licensing Deal Over FTC Concerns
Sanofi has terminated its global licensing agreement with Maze Therapeutics for Pompe disease treatment, citing issues related to FTC regulations.
Maze and Shionogi Collaborate on Pompe Disease Program
Maze Therapeutics partners with Shionogi to develop a new program targeting Pompe disease. Explore innovative treatments and advancements in genetic disorders.
Maze Therapeutics' Key Advances in Chronic Kidney Disease Therapies
Explore Maze Therapeutics' progress with MZE829 and MZE782, innovative treatments targeting chronic kidney disease. Learn more about these leading programs.
Maze Reports $9.03M Profit in Q3 2024, Rebounding from $73.84M Loss
Maze Technologies sees a major turnaround, reporting a $9.03 million profit for the nine months ending September 30, 2024, compared to a $73.84 million loss last year.